| CAT No: | CL-RGN-26 |
| CAS No: | NA |
| Mol.F: | C27H31D5N2O5 |
| Mol.Wt.: | 473.6 |
| Chemical Name: | 2-(ethoxy-d5)-4-(2-(((1S)-1-(2-(3-hydroxypiperidin-1-yl)phenyl)-3-methylbutyl)amino)-2-oxoethyl)benzoic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to 3-hydroxy Repaglinide D5 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
3-hydroxy Repaglinide D5 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(ethoxy-d5)-4-(2-(((1S)-1-(2-(3-hydroxypiperidin-1-yl)phenyl)-3-methylbutyl)amino)-2-oxoethyl)benzoic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Repaglinide Molecular Formula: C27H31D5N2O5
Molecular Weight: 473.6
Storage: Store in a cool, dry place.
| Product Name: | 3-hydroxy Repaglinide D5 |
| CAS No: | |
| Mol.F.: | C27H31D5N2O5 |
| Mol.Wt.: | 473.6 |
Cat. No: CL-RGN-01
CAS No: 135062-02-1
Mol. F: C27H36N2O4
Mol. Wt: 452.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-02
CAS No: 220438-80-2
Mol. F: C11H12O5
Mol. Wt: 224.2
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-03
CAS No: 99469-99-5
Mol. F: C13H16O5
Mol. Wt: 252.3
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-04
CAS No: 147769-93-5
Mol. F: C16H26N2
Mol. Wt: 246.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-05
CAS No: 147770-06-7
Mol. F: C29H40N2O4
Mol. Wt: 480.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-06
CAS No: 147852-26-4
Mol. F: C27H36N2O4
Mol. Wt: 452.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-NO-01
CAS No: NA
Mol. F: C16H25N3O
Mol. Wt: 275.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-07
CAS No: 110017-07-7
Mol. F: C12H15BrO3
Mol. Wt: 287.2
Inv. Status: Custom Synthesis
.jpg)
Cat. No: CL-RGN-08
CAS No: 219921-94-5
Mol. F: C16H26N2 : C7H11NO5
Mol. Wt: 246.4 : 189.2
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-09
CAS No: 503834-19-3
Mol. F: C12H14O5
Mol. Wt: 238.2
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-10
CAS No: NA
Mol. F: C12H14N2 : HCl
Mol. Wt: 186.3 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-11
CAS No: 1039989-55-3
Mol. F: C16H26N2
Mol. Wt: 246.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-12
CAS No: 1803084-79-8
Mol. F: C30H34N2O4
Mol. Wt: 486.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-13
CAS No: 874908-11-9
Mol. F: C22H28N2O4
Mol. Wt: 384.5
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-14
CAS No: 2519482-34-7
Mol. F: C27H34N2O4
Mol. Wt: 450.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-15
CAS No: 2519482-33-6
Mol. F: C27H34N2O4
Mol. Wt: 450.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-16
CAS No: 99470-01-6
Mol. F: C13H15NO3
Mol. Wt: 233.3
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-17
CAS No: 332347-69-0
Mol. F: C15H20O5
Mol. Wt: 280.3
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-18
CAS No: 107362-46-9
Mol. F: C19H24N2
Mol. Wt: 280.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-19
CAS No: NA
Mol. F: C17H26N2
Mol. Wt: 258.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-20
CAS No: 88709-17-5
Mol. F: C12H16O3
Mol. Wt: 208.3
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-21
CAS No: NA
Mol. F: C16H26N2 : C7H11NO5
Mol. Wt: 246.4 : 189.2
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-22
CAS No: 765306-65-8
Mol. F: C16H24N2O
Mol. Wt: 260.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-23
CAS No: 147769-96-8
Mol. F: C16H24N2
Mol. Wt: 244.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-24
CAS No: 99469-97-3
Mol. F: C15H24N2
Mol. Wt: 232.4
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-25
CAS No: 1337189-86-2
Mol. F: C14H22N2
Mol. Wt: 218.3
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-27
CAS No: 1217709-85-7
Mol. F: C27H31D5N2O4
Mol. Wt: 457.6
Inv. Status: Custom Synthesis
Cat. No: CL-RGN-28
CAS No: NA
Mol. F: C27H31D5N2O6
Mol. Wt: 489.6
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: